Capture-based ultra-deep sequencing in plasma ctDNA reveals the resistance mechanism of ALK inhibitors in a patient with advanced ALK-positive NSCLC

DOI: 10.1080/15384047.2018.1433496

Keywords: NSCLC, ALK inhibitors, Acquired resistance, ctDNA, MET

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text